Recruiting

tVNS

Sponsor:

Shirley Ryan AbilityLab

Code:

NCT07951489

Conditions

TBI Traumatic Brain Injury

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Transcutaneous Vagus Nerve Stimulation (tVNS)

Tancutaneous Vagus Nerve Stimulation (Sham then Active)

Study Details

Brief summary:

The purpose of this study is to evaluate whether individuals with TBI can comfortably and consistently use transcutaneous vagus nerve stimulation (tVNS) at home and to identify barriers that may affect participation. A secondary objective is to obtain preliminary data to examine whether at-home tVNS is associated with improvement in cognitive skills as well as any improvement in patient reported outcomes such as sleep, mood, or fatigue.

Conditions

TBI Traumatic Brain Injury

Study ID

NCT07951489

Start date

Dec, 2026

Status verified date

Nov, 2026

Completion date

Mar, 2029

Anticipated

Primary completion date

Dec, 2028

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Age 18-75 years Formally diagnosed with traumatic brain injury.
  • Ability to independently use a keyboard.
  • Ability to independently apply the electrode and adjust stimulation or have a designated caregiver available to be trained and assist with these tasks.
  • Able to understand and communicate in English (according to clinical judgment).
  • Able to independently provide consent to participate. -Able to come in person to Shirley Ryan AbilityLab in Chicago, IL for three visits over 5 weeks.

Exclusion Criteria:

  • Acute medical issues requiring close physician or nursing monitoring. Bioelectrical implants, cerebral shunts, including pacemakers.
  • Anyone with sore or diseased skin area in the ear
  • Pregnancy or persons who are lactating.
  • Cardiac arrhythmia.
  • Epilepsy or seizure disorders.
  • Significant gross or fine motor weakness.
  • Significant, ongoing communication or comprehension impairments (such as aphasia) that would affect an individual's ability to complete the required assessments.
  • Severely impaired memory retention
  • Current major depression diagnosis.

Study Design

Enrollment

30 participants

Anticipated

Allocation

Randomized

Intervention Model

Crossover

Primary purpose

Treatment

Interventions and Outcome Measures

Arms

experimental: Active Stimulation

Initial baseline assessment completed Day 0. Active stimulation using Tancutaneous Vagus Nerve Stimulation (tVNS) device , for atleast one hour a day for 14 days at home (Day1-14). A mid intervention assessment session completed on Day 15. Following that assessment, another two weeks (Day 16-29) of active stimulation at home followed by a post intervention assessment session.

sham comparator: Sham Stimulation

Initial baseline assessment completed Day 0. Sham stimulation using Tancutaneous Vagus Nerve Stimulation (tVNS) device, for atleast one hour a day for 14 days at home (Day1-14). A mid intervention assessment session completed on Day 15. Following that assessment, participant will switch to recieve active stimulation for the remaining 2 week at home (Day 16-29) followed by a post intervention assessment session.

Interventions

Transcutaneous Vagus Nerve Stimulation (tVNS)

tVNS stimulation at home for atleast one hour a day for 4 weeks.

Tancutaneous Vagus Nerve Stimulation (Sham then Active)

Participants will recieve two weeks of sham stimulation for atleast one hour a day, followed by 2 weeks of active stimulation for atleast one hour a day.

Primary outcome measure

  • Recording the number of participant who completed at least 75% of the sessions out of the number of participants enrolled in the study. [ Time Frame: Post Intervention Assessment Day 30 ]
  • Semi-structured interviews will collect feedback on perceived benefit, usability, logistical challenges, and barriers to adherence. [ Time Frame: Post Intervention Assessment Session Day 30 ]

Central Contacts and Locations

Central contacts

Kathryn Magee, MHS., CCC-SLP/L, CBIS

312 238 6451tvns_research@sralab.org

Shira Cohen-Zimerman, PhD

312 238 6450tvns_research@sralab.org

Locations

Shirley Ryan AbilityLab

Recruiting

Chicago, Illinois, United States, 60611

More Information

Sponsor

Shirley Ryan AbilityLab

Last update posted

Nov 20, 2026

Last verified

Nov, 2026

Keywords

  • Traumatic Brain Injury
  • Executive Functions
  • Transcuaneous Vagus Nerve Stimulation (tVNS)

Trial information was received from ClinicalTrials.gov and was last updated on 2026-11-21. This information was provided to ClinicalTrials.gov by Shirley Ryan AbilityLab on 2026-11-20. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.